News & Reports

News and Reports

Fierce Healthcare: Trump order seeks changes to Medicare drug price negotiation program, PBM reform

The provision’s inclusion was not supported by Patients for Affordable Drugs, calling it a “deeply harmful” item that caves to pharmaceutical lobbyists. “It would hand drug companies four additional years to price-gouge patients, one in three of whom can’t afford their prescription drugs today,” said Executive Director Merith Basey. “This change isn’t about supporting innovation […]

News and Reports

Healthcare Finance: Trump's executive order on drugs seeks to end pharma 'pill penalty'

Merith Basey, executive director of Patients For Affordable Drugs, said the small molecule provision in the EO caves to pharmaceutical lobbyists’ demands. “Delaying Medicare negotiation for small-molecule drugs – the most commonly used medications – is a clear giveaway to Big Pharma,” Basey said. “It would hand drug companies four additional years to price-gouge patients, […]

News and Reports

Common Dreams: 'Trump Just Caved to Big Pharma—Again': New Order Aims to Delay Drug Price Negotiations

“Make no mistake,” Patients for Affordable Drugs executive director Merith Basey said of the legislation, “this is yet another attempt by Big Pharma to rig the system in its favor—at the expense of patients.”

News and Reports

Nation of Change: Trump executive order hands Big Pharma a major win by delaying Medicare drug price negotiations

“Make no mistake,” said Merith Basey, executive director of Patients for Affordable Drugs, “this is yet another attempt by Big Pharma to rig the system in its favor—at the expense of patients.”

News and Reports

Fierce Pharma: Trump throws pharma 'bread crumb' concession with call to end IRA pill penalty

In her own statement, Merith Basey, executive director of Patients for Affordable Drugs, agreed that the proposed elimination of the pill penalty is “a clear giveaway to Big Pharma.”

News and Reports

NBC 5: President Trump says tariffs on pharmaceuticals are coming soon

“One in three people cannot afford to fill their prescription drugs today,” said Patients for Affordable Drugs Executive Director Merith Basey. “There is real concern, understandably, that these tariffs would increase costs for patients and make their lives much harder.”

News and Reports

CNN: Trump drug tariffs would drive up prices, worsen shortages before any boost to US manufacturing, experts warn

“Tariffs will exacerbate that problem,” said Merith Basey, Executive Director of the advocacy group Patients For Affordable Drugs. “Prescription drugs aren’t luxury goods; they’re essential to people’s health and survival.”

News and Reports

AXIOS: First look: Trump is urged to keep drug negotiations

A new ad campaign by P4AD asks the administration to maintain Medicare drug price negotiation process.